What is Edwards Lifesciences's R&D?

Edwards Lifesciences (EW) reported R&D of $263.3M in Q1 2026.

How has Edwards Lifesciences's R&D changed year-over-year?

Edwards Lifesciences's R&D increased by 3.4% year-over-year, from $254.6M to $263.3M.

What is the long-term trend for Edwards Lifesciences's R&D?

Over 4 years (2021 to 2025), Edwards Lifesciences's R&D has grown at a 4.6% compound annual growth rate (CAGR), from $903.1M to $1.08B.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Edwards Lifesciences EW R&D

R&D at other companies

AbbottABT

$767M+7.1%

Merit Medical SystemsMMSI

$22.61M+0.6%

ICU MedicalICUI

$21.28M-8.6%

LeMaitre VascularLMAT

$4.06M-0.9%

MedtronicMDT

$671M-1.9%

TFX

TeleflexTFX

$44.39M+75.5%

Other financials

Income statement

See full

Revenue$1.6B+16.7%

Gross profit$1.3B+15.7%

Operating income$477.6M+21.0%

Net income$380.7M+6.3%

EPS (diluted)$0.66+8.2%

Balance sheet

See full

Cash & equivalents$2.4B-22.3%

Total debt$702.9M+0.5%

Total equity$10.3B+2.0%

Total assets$13.3B+2.3%

Cash flow

See full

Operating cash flow$43.8M-84.4%

CapEx$64.9M+15.9%

Free cash flow-$21.1M-109%

Valuation

See full

Market cap$52.27B+17.5%

Enterprise value$50.53B+20.6%

P/E47.7×+37.0×

P/S8.3×+0.5×

Profitability

See full

Gross margin77.9%-1.6pp

Operating margin21.4%-4.4pp

Net margin17.4%-58.3pp

FCF margin17.3%—

Returns & leverage

See full

Return on equity10.7%-37.8pp

Debt / equity0.1×0.0×

Current ratio4.4×0.0×

Where this comes from

Reported directly by Edwards Lifesciences in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Edwards Lifesciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Edwards Lifesciences's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Edwards Lifesciences's R&D?: Edwards Lifesciences (EW) reported R&D of $263.3M in Q1 2026.
How has Edwards Lifesciences's R&D changed year-over-year?: Edwards Lifesciences's R&D increased by 3.4% year-over-year, from $254.6M to $263.3M.
What is the long-term trend for Edwards Lifesciences's R&D?: Over 4 years (2021 to 2025), Edwards Lifesciences's R&D has grown at a 4.6% compound annual growth rate (CAGR), from $903.1M to $1.08B.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.